Related Experiment Video
Updated: Jun 1, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Discrimination between the enzymatic activities of Candida albicans pleomorphic forms determined using the api® ZYM
M Staniszewska1, D Rabczenko, W Kurzątkowski
1Independent Laboratory of Streptomyces and Fungi Imperfecti, National Institute of Public Health-National Institute of Hygiene, Warsaw, Poland. mstaniszewska@pzh.gov.pl
Enzymatic activity profiles differ significantly between Candida albicans yeast and hyphal forms, with only leucine arylamidase showing strong agreement. These differences may impact pathogenesis and warrant further investigation for clinical applications.
Area of Science:
- Medical Mycology
- Clinical Microbiology
- Enzymology
Background:
- Candida albicans exhibits pleomorphism, existing as yeast (blastoconidia) and hyphal forms.
- Different morphotypes may possess distinct biochemical characteristics relevant to pathogenesis.
- Understanding enzymatic differences can aid in diagnostics and therapeutic strategies.
Purpose of the Study:
- To compare enzymatic activity profiles between yeast and hyphal morphotypes of Candida albicans clinical isolates.
- To assess the agreement of enzymatic activities between the two morphotypes using the api(®) ZYM system.
- To explore the clinical implications of observed enzymatic differences.
Main Methods:
- Cultivation of 37 Candida albicans clinical isolates in yeast extract-peptone-glucose broth (yeast form) and human serum (hyphal form).
- Documentation of morphotypes using scanning electron microscopy.
- Evaluation of enzymatic activity profiles using the api(®) ZYM test.
Main Results:
- No significant agreement (kappa > 0.80) in overall enzymatic activity profiles between yeast and hyphal morphotypes.
- Leucine arylamidase activity showed significant agreement (kappa = 0.770) in 35 out of 37 strains.
- Weak to moderate agreement was observed for other hydrolytic enzymes, suggesting distinct profiles for each morphotype.
Conclusions:
- Significant differences in enzymatic activity exist between Candida albicans blastoconidia and hyphae.
- These enzymatic variations may be linked to the distinct roles of each morphotype during infection.
- Further research into these differences, including strain biotyping and specific enzyme activities like Beta-N-hexosaminidase (HexNAcase), is recommended for clinical benefit.
More Related Videos
07:19A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms
Published on: October 21, 2010
06:50A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022